| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/11/2003 | WO2002073062B1 Synthetic molecular spring device |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002063975A3 Feed additive compositions and methods |
| 12/11/2003 | WO2002061085A3 Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
| 12/11/2003 | WO2002060928A3 Medane genes and proteins |
| 12/11/2003 | WO2002057455A3 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof |
| 12/11/2003 | WO2002048191A3 Inhibitory agents derived from specific growth factors |
| 12/11/2003 | WO2002046212A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/11/2003 | WO2002036623A3 Ghep, a gene highly expressed in normal and neoplastic prostate, and uses therefor |
| 12/11/2003 | WO2002022780A8 Methods and materials relating to neuropilin-like polypeptides and polynucleotides |
| 12/11/2003 | WO2002000939A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 12/11/2003 | WO2000070054A9 Pathogen-resistant grape plants |
| 12/11/2003 | WO1999024553A3 X-ray crystal comprising hiv-1 gp120 |
| 12/11/2003 | US20030229925 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 12/11/2003 | US20030229924 Comprises nucleotide sequences coding arabidopsis late flowering protein (VIN4) for genetically engineering crops with increased yield and biomass |
| 12/11/2003 | US20030229922 Comprises nucleotide sequences coding enzymatic polypeptide that modifies plant polysaccharides of cell wall for preparing cellulose acetate, synthetic textiles, biodegradable plastics and digestible medicine capsules |
| 12/11/2003 | US20030229919 Polypeptide compositions toxic to anthonomus insects, and methods of use |
| 12/11/2003 | US20030229915 Plant gene sequences II |
| 12/11/2003 | US20030229913 Transgenic fish embryo with reduced endothelial growth factor (FLT1) expression for treating tumorous disorders; antisense therapy; angiogenesis inhibitors |
| 12/11/2003 | US20030229912 Non-human transgenic mammals and their use as a disease model |
| 12/11/2003 | US20030229907 Transgenic non-human mammals with progressive neurologic disease |
| 12/11/2003 | US20030229906 Preventing kidney cell dedifferentiation and viral nephropathy using peptide inhibitors; enzyme inhibitors; viricides; mimetics |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229216 Constitutively activated human G protein coupled receptors |
| 12/11/2003 | US20030229215 Comprises nucleotide sequences coding transport proteins for use as tool in biological pest control; insecticides |
| 12/11/2003 | US20030229214 Comprises polynucleotide coding peptides or polypeptides associated with viral envelope protein for preventing infection and/or killing lymphadenopathy associated viral diseases; viricides; immunotherapy |
| 12/11/2003 | US20030229211 Isolating an endotoxin binding protein from horseshoe crab for treatment of septic shock |
| 12/11/2003 | US20030229210 Process for the preparation of active somatotropin from inclusion bodies |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229205 Silver halide emulsion for improving photographic products such as photographic paper or cellulose films |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229203 Chemokine variants and methods of use |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229200 Useful in treating or preventing obesity |
| 12/11/2003 | US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers |
| 12/11/2003 | US20030229120 Zinc binding ligand; sustained release of insulin |
| 12/11/2003 | US20030229045 CFTR gene regulator |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229042 Methods and compositions for therapies using genes encoding secreted proteins |
| 12/11/2003 | US20030229038 Lunasin peptides |
| 12/11/2003 | US20030229035 Method of restoring ciliated cell motility |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030229017 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 12/11/2003 | US20030229016 Genetic engineering; binding to antibody |
| 12/11/2003 | US20030229015 Atherosclerosis; anticholesterol agents |
| 12/11/2003 | US20030229014 Agents and methods for promoting bone growth |
| 12/11/2003 | US20030229013 Drug delivery |
| 12/11/2003 | US20030229011 Humanized lactoferrin and uses thereof |
| 12/11/2003 | US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization |
| 12/11/2003 | US20030229009 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/11/2003 | US20030229006 Amphiphilic oligomers |
| 12/11/2003 | US20030228700 Provides compounds useful as multifunctional labels in proteomics studies; labels are both lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies |
| 12/11/2003 | US20030228696 Novel insect cell line |
| 12/11/2003 | US20030228677 AMID protein, nucleic acid molecules, and uses thereof |
| 12/11/2003 | US20030228672 Comprises nucleotide sequences coding oxidoreductases for transformation and fermentive production of 2-keto-L-gulonic acid |
| 12/11/2003 | US20030228667 Modulator of nuclear factor alpha beta for treating defects in immune responses, stress responses, inflammation or apoptosis |
| 12/11/2003 | US20030228666 Comprises thrombopoietin derivative for treating and preventing thrombocytopenia |
| 12/11/2003 | US20030228665 Production of human parathyroid hormone from microorganisms |
| 12/11/2003 | US20030228664 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2003 | US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders |
| 12/11/2003 | US20030228661 Genes encoding sulfate assimilation proteins |
| 12/11/2003 | US20030228659 Novel angiopoietin materials and methods |
| 12/11/2003 | US20030228658 Comprises nucleotide sequences coding membrane protein for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating melanomas, pigmentation disorders and inflammation; forensics; drug screening |
| 12/11/2003 | US20030228657 Methods for enhancing the translation and expression of recombinant proteins |
| 12/11/2003 | US20030228656 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2003 | US20030228655 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/11/2003 | US20030228654 Method for producing antimicrobial protein and fusion protein |
| 12/11/2003 | US20030228653 Novel orphan cytokine receptor polypeptides |
| 12/11/2003 | US20030228652 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/11/2003 | US20030228640 Using early prostate antigen as tool in diagnosis, prognosis and treatment of cancer |
| 12/11/2003 | US20030228634 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 12/11/2003 | US20030228633 Compounds that activate the olfactory CNG channel will enhance smell and can be used to make foods more palatable for individuals with attenuated olfactory function |
| 12/11/2003 | US20030228630 Proteome analysis method and proteome analysis system |
| 12/11/2003 | US20030228619 Using labeled peptidic nucleotide sequences to screen coded synthetic libraries for non-linear, non-polymeric, heterocyclic molecules |
| 12/11/2003 | US20030228612 Comprises nucleotide sequences coding epidermal growth factor protein (EGF) for treating liver and gastrointestinal disorders; wound healing agents; bioreactors |
| 12/11/2003 | US20030228606 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 12/11/2003 | US20030228592 Human facilitative glucose transport protein GLUT8 |
| 12/11/2003 | US20030228588 Providing a support carrying primary amine groups, coupling an N-protected peptide nucleotide to the support, removing N-terminal protecting group, coupling an N-protected nucleotide to derivatised support, repeating above steps |
| 12/11/2003 | US20030228587 IWU-1 is a protein of 115 amino acids with a calculated molecular mass of 12.9 kDa, cloned from a cDNA molecule of human bone marrow having 347 nucleotides |
| 12/11/2003 | US20030228584 Novel nucleic acids and polypeptides |
| 12/11/2003 | US20030228581 Comparing the nucleotide sequence encoding the AIF protein from a human biopsy to a wild-type |
| 12/11/2003 | US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS) |
| 12/11/2003 | US20030228569 Methods and compositions for high yield production of eukaryotic proteins |
| 12/11/2003 | US20030228371 Anti-infarction molecules |
| 12/11/2003 | US20030228353 Wound heraling agents; polypeptide |
| 12/11/2003 | US20030228345 Genetic engineered protein; bone disorders |
| 12/11/2003 | US20030228329 Genetic engineering; insertion of gene; generating immunology response |
| 12/11/2003 | US20030228328 Vaccine for periodontal disease |
| 12/11/2003 | US20030228326 Administering antigen; anticancer agents; transfection human cells |
| 12/11/2003 | US20030228323 Protein vaccine; culture product; genetic engineering |
| 12/11/2003 | US20030228318 PSCA: prostate stem cell antigen and uses thereof |
| 12/11/2003 | US20030228317 Antitumor agents; anticancer agents |
| 12/11/2003 | US20030228312 TNF receptor-specific antibodies |
| 12/11/2003 | US20030228308 Immunology active materials; complexing; anticancer agents |